Bronchial asthma (BA) is a chronic inflammatory disease of the airways in the pathogenesis of which oxidative stress has a very important role. Single nucleotide polymorphisms (SNPs) in catalase gene may result in decreased antioxidative defense capacity, and thus a higher risk for BA development. Since oxidative stress has an important role in the pathogenesis of BA and catalase has a key role in antioxidant defense, the aim of this study was to examine the association of CAT C-262T polymorphism with BA in Serbian patients with BA.
I NT ROD U CT I ON
Bronchial asthma (BA) is a complex chronic inflammatory disease of the airways, the pathophysiology of which is not completely understood. It is considered that BA is a result of complex interaction between different genetic and environmental factors. Lungs are prone to damage caused by reactive oxygen species (ROS) due to the large surface that is directly exposed to high oxygen pressure and different irritants. Moreover, the lungs are exposed to microbes and the process of their elimination in order to keep airways sterile results in higher ROS production (1) . High ROS levels, caused by increased ROS production or/and decreased antioxidant cellular capacity, results in oxidative stress which subsequently induces direct or indirect ROS-mediated damage of lipids, proteins and nucleic acids (2) . Oxidative stress increases inflammation and bronchial hyperreactivity, stimulates bronchospasm and increases mucussecretion in BA (3) .
An adequate induction of antioxidant mechanisms is of great importance for the homeostasis of cellular functions. Under the physiological conditions, different enzymatic (catalase, superoxide-dismutase, glutathione peroxidase) and non-enzymatic (vitamins C and E, glutathione, bilirubin, coenzyme Q) antioxidant systems keep reducing the redox state. Catalase (E.C.1.11.1.6) is an antioxidant enzyme that decomposes hydrogen peroxide (H2O2) to molecular oxygen and water. It is present in almost all mammalian cells, mainly in peroxisomes and mitochondria with an exception of erythrocytes where enzyme is located in cytoplasm. However, catalase may be released into the extracellular environment where it has the potential to function as antioxidant and regulator of cell survival (4) . Catalase is especially active in the presence of high concentrations of H2O2, but in a prolonged oxidative stress its activity notably decreases due to the oxidation of NADP to NADP+ (1) .
Human catalase is coded by the gene located on the short arm of the chromosome 11. It consists of 13 exons and 12 introns and codes 256 amino acid long protein. Catalase gene contains 8 transcription initiation sites, 3 CCAAT and 3 GC-like boxes, but it does not contain TATA box,initiating consensus sequence in the promoter region, which results in the numbers of transcription initiation sites (5) . The regulation of catalase gene expression significantly influences the total amount of the enzyme and it is regulated by the different mechanisms involving peroxisome proliferator-activated receptor gamma (PPARγ), tumor necrosis factor α (TNF-α), p53 and CpGhypermethylation in the promoter of catalase gene (6) .
Single nucleotide polymorphisms (SNPs) located in genes coding the antioxidant enzymes may modify the inter-individual variability in the defense capacity against oxidative stress by altering enzymes structure, substrate specificity or enzyme activity (7) . One of the common polymorphisms in catalase gene (CAT C-262T, rs1001179) leads to the substitution of cytosine (C) by thymine (T) at the position -262. This SNP is located in the promoter region of catalase gene and may influence transcription by changing the binding of transcription factors, and thus alter basal catalase expression in differrent cell types (6) . Homozygous mutant genotype CAT-262TT could be associated with reduced antioxidant defense, and thus, increased oxidative stress in BA. However, the precise role of this SNP in BA is still not elucidated.
Since oxidative stress has an important role in the pathogenesis of BA and catalase has a key role in antioxidant defense, the aim of this study was to examine the association of CAT C-262T polymorphism with BA in the Serbian patients with BA.
MATERIALS AND METHODS

Patients
A total of 170 subjects, inhabitants of the southeast Serbia, were enrolled in this study. All participants were divided into two groups:
• Group I included 79 patients with BA (32 male and 47 female; mean age 47.48 ± 15.81 years) diagnosed at the Clinic for Pulmonary Diseases and Tuberculosis Knezselo, Clinical Center Niš, Serbia. Bronchial asthma was diagnosed according to GINA (Global Initiative for Asthma) protocol.
• Group II included 91 unrelated healthy volunteers (45 male and 46 female; mean age 46.81 ± 16.78 years). Control group involved healthy volunteers without previous history of BA and/or atopy, as well as the absence of other acute and chronic diseases.
All individual participants included in the study signed an informed consent prior to study entry. This study was conducted in accordance with the principles of the Declaration of Helsinki and the good laboratory practice, and was approved by the Ethical Committee of the Faculty of Medicine, University of Niš, Serbia.
Samples
Blood samples were collected in the vacutainers with ethylenediaminetetraacetic acid (EDTA) as an anticoagulant during the routine laboratory testing by the cubital vein punction. DNA was isolated from 200 µl of the whole blood according to the manufacturer protocol (QIAamp DNA Blood Mini Kit, Quiagen GmbH, Hilden, Germany) and stored at -20 °C until further experiments were performed.
SNP genotyping
The CAT C-262T polymorphism was determined using polymerase chain reaction -restriction fragment length polymorphism (PCR-RFLP) technique. PCR was performed in a final volume of 25 µl containing 20 ng of DNA, 12.5 µl KAPA2G Fast HotStartReadyMix (Kapa Biosystems, Inc, USA) and 20 pmol of each primer (F 5'-TAA GAG CTG AGA AAG CAT AGC T-3'; R 5'-AGA GCC TCG CCC CGC CGG ACC G-3'). Initial denaturation step at 95 °C for 2 min was followed by 35 cycles of denaturation step at 95 °C for 15 s, annealing step at 63 °C and extension step at 72 °C for 15 s. Final extension step was performed at 72 °C for 1 min. The obtained PCR products were identified by 2% agarose gel electrophoresis. Gels were stained with ethidium bromide and visualized under UV light. Afterwards, the obtained PCR products were digested at 37 °C for 15 min using FastDigestSmaI restriction enzyme (Fermentas GmbH, St. Leon-Rot, Germany) and analyzed by 8% polyacrylamide gel electrophoresis. The genotype was denoted as mutant homozygous or TT if 185 bp band was detected, heterozygous or CT if three bands were detected (185 bp, 155 bp and 30 bp) and wild type or CC if 155 bp and 30 bp bands were detected.
All genotype analyses were performed by two independent researchers. After the polymorphic alleles were established to be homozygous for the mutant genotype, the PCR-RFLP was repeated in order to confirm the obtained results.
Statistical analysis
Chi-square (χ 2 ) test or two-tailed Fisher's test, when the number of expected cases was small, was used for testing the differences in genotype and allele frequencies between patients and controls. The genetic risk magnitudes were assessed by calculating odds ratios (OR) with 95% confidence intervals (95% CI). Probability values p < 0.05 were considered significant.
RE S U LT S
The genotype frequencies for CAT C-262T SNP were in Hardy-Weinberg equilibrium (p > 0.05), except for female patients with BA where genotype distribution was not in Hardy-Weinberg equilibrium (p < 0.05).
The most frequent genotype in BA patients was heterozygous CT with 48.10%. Homozygous CC genotype was detected in 45.57%, while mutant TT genotype was detected in only 6.33% of BA patients. The distribution of genotypes in controls was as follows: 50.55% CC, 41.76% CT and 7.69% TT. The analysis of genotype distribution did not show statistically significant differences between BA patients and healthy controls (Table 1) . Moreover, no differences were detected when comparison was performed based on dominant and recessive model (Table 1) . No significant difference in the distribution of CAT-262C and CAT-262T alleles between patients and healthy controls were observed (p = 0.715; OR = 1.091; 95% CI = 0.684-1.741; Table 2 ). n -number of subjects; BA -bronchial asthma; χ 2 -chi-square test; OR -odds ratio; CI -confidence interval; p -p-value Table 3 represents the distribution of CAT C-262T genotypes and alleles in BA and controls stratified by sex. The analysis of genotype and allele distributions, based on stratification by sex, did not differ significantly between BA patients and healthy controls (p > 0.05). M -male; F -female; BA -bronchial asthma; n -number of subjects
O r i g i n a l a r t i c l e
DI SCU SSI ON
Catalase, together with other antioxidativeenzymes, such as superoxide dismutase and glutathione peroxidase, represents the first line enzymatic defense from oxidative stress. Single nucleotide polymorphisms in the catalase gene may alter the susceptibility to oxidative stress-mediated injury. Since it was previously shown that BA is a complex disease associated with increased oxidative stress, the aim of this study was to examine the possible association of catalase C-262T SNP with BA.
SNPs located in genes that code the antioxidative enzymes, such as catalase, may be responsible for altered enzyme structure, substrate specificity or enzyme's activity, and thus, modified defense capacity against oxidative stress. Experimental studies showed that catalase activity is up to 50% lower in bronchoalveolar lavage of asthmatic lungs compared to healthy controls, which is considered to be the result of protein oxidative modification and not the decreased amount of enzyme (1, 8) . Moreover, erythrocytes of the asthmatic children showed decreased catalase activity compared to healthy children (9) .
Among more than 200 SNPs identified in catalase gene (e.g. A-21T -rs793316; C-262T -rs1001179 and C-844T -rs769214) C-262T is the most studied. This polymorphism has been studied in different populations and in different pathophysiological conditions giving contradictory results. CAT C-262T is located in the promoter region of catalase gene and it is suggested that this SNP may influence transcription by changing the binding of transcription factors leading to altered basal catalase expression in different cell types (6) . The association of mutant CAT-262T allele with acatalasia has been previously shown (10) . It was also shown that carriers of CAT-262CC had higher activity of CAT compared to those with -262CT or -262TT genotypes (11, 12) .
Homozygous CAT-262TT genotype was present in 22.6% of children with BA compared to 4.8% healthy children in the Slovak population (13) . Similar distribution of CAT C-262T genotypes was observed in European population, as well as in Hong Kong Chinese (14 -18). In our study, mutant CAT-262TT genotype was detected in 6.33% BA patients and 7.69% healthy controls. The distribution of genotypes and alleles of CAT C-262T SNP was not significantly different between BA patients and controls in our study. Also, no differences were observed after stratification of the subjects by sex. Our results are in accordance with the results obtained by Mak et al. (18) , Polonikov et al. (19) and Wenten et al. (20) . However, Polonikov et al. suggested that another CAT A-21T (rs793316) SNP was associated with increased oxidative stress and increased BA risk due to decreased enzyme activity (19) , but some other studies failed to reveal this association (18, 21) . The homozygous CAT C-262T variant was associated with BA in the Slovak children (13) . Furthermore, white children of Hispanic origin, carriers of genotypes with the mutant CAT-262T allele (CT or TT), were at an increased risk for new onset of asthma compared to the children who were homozygous for the common allele (CAT-262C), while among non-Hispanic white children this polymorphism was not associated with BA risk (22) .
Even that the catalase SNPs are not intensively studied in BA, results available in the literature are very contradictory. These discrepancies partially may be the result of ethnical differences among the subjects involved in these studies. Furthermore, the differences between the studies could be due to gene-gene and geneenvironment interactions in complex diseases, such as BA. Thus, further studies performed in different populations and on the larger sample sizes are needed in order to elucidate the role of genetic polymorphisms in catalase gene in the pathogenesis of BA.
CONCL U S I ON
This is the first study that examined CAT C-262T (rs1001179) SNP in Serbian patients with BA. The results obtained in this study show that the biallelic SNP at the position -262 in the catalase gene is not associated with BA in the Serbian population.
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